Treatment combination with anti-folr1 immune window

• 收藏
• 分享

专利权人:

发明人:

申请号：

RU2018111205

公开号：

RU2018111205A3

申请日:

申请国别(地区):

RU

年份:

2019

代理人:

摘要：

Therapeutic combinations of immunoconjugates that bind to FOLR1 (e.g., IMGN853) with anti-VEGF agents (e.g., bevacizumab), a platinum-based agent, and/or doxorubicin are provided. Methods of administering the combinations to treat cancers, e.g., ovarian cancers, with greater clinical efficacy and/or decreased toxicity are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/